首页> 外文期刊>BMC Pediatrics >Genotypes of glycoprotein B gene among the Indian symptomatic neonates with congenital CMV infection
【24h】

Genotypes of glycoprotein B gene among the Indian symptomatic neonates with congenital CMV infection

机译:印度先天性巨细胞病毒感染的有症状新生儿糖蛋白B基因的基因型

获取原文
获取外文期刊封面目录资料

摘要

Cytomegalovirus [CMV] is a causative agent of congenital infection worldwide and often leads to neurological deficits and hearing loss in newborns. Infants born with symptomatic congenital Cytomegalovirus infection [cCMV] are at significant high risk for developing adverse long-term outcomes. In this study, we look into the sequence variability of surface glycoprotein B [gB] encoding region in newborns with symptomatic CMV infection for the first time in Eastern region of India. 576 suspected newborns from seropositive mothers were subjected to the study and ELISA was used to confirm CMV infection. Different genotypes and their subtypes were determined using multiplex nested-PCR. Viral load of different glycoprotein B [gB] genotypes was measured using RT-PCR. Sequencing and phylogenetic analysis was then performed using Bayesian interference. The overall frequency of cCMV infection was 18.4%, where 16.0% neonates were symptomatic. Among the different gB genotypes, gB1 had the highest frequency [23.5%] and gB4 showed the lowest occurrence [5.8%]. 23.5% of symptomatic neonates had mixed genotypes of gB, probably indicating matrenal reinfection with CMV strains in Indian population. Significant genotypic clades [gB1-gB2-gB3-gB5] were grouped closely based on gene sequences, but the gB4 sequence was in the outlier region of the phylogenetic tree indicating the genetic polymorphism. This is the first study on cCMV genotyping and its phylogenetic analysis from Eastern Indian neonatal population. The study holds importance in the assessment of cCMV seroprevalence in global perspective. gB protein can be used as a potential therapeutic target against CMV infection.
机译:巨细胞病毒[CMV]是全世界先天性感染的病原体,通常会导致新生儿神经功能缺损和听力下降。有症状的先天性巨细胞病毒感染[cCMV]出生的婴儿处于长期不良后果的显着高风险。在这项研究中,我们首次在印度东部地区调查了有症状CMV感染的新生儿中表面糖蛋白B [gB]编码区的序列变异性。对576名血清阳性母亲的疑似新生儿进行了研究,并使用ELISA确认了CMV感染。使用多重巢式PCR确定不同的基因型及其亚型。使用RT-PCR测量了不同糖蛋白B [gB]基因型的病毒载量。然后使用贝叶斯干扰进行测序和系统发育分析。 cCMV感染的总频率为18.4%,其中有症状的新生儿为16.0%。在不同的gB基因型中,gB1的频率最高[23.5%],而gB4的频率最低[5.8%]。有症状的新生儿中有23.5%患有混合型gB基因型,这可能表明印度人群中CMV株的母体再感染。重要基因型进化枝[gB1-gB2-gB3-gB5]根据基因序列紧密分组,但gB4序列位于系统发育树的离群区域,表明遗传多态性。这是来自东印度新生儿的有关cCMV基因分型及其系统发育分析的第一项研究。该研究在全球范围内对评估cCMV血清阳性率具有重要意义。 gB蛋白可用作对抗CMV感染的潜在治疗靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号